• Needham PROSE Clinic
  • Find a PROSE Clinic
  • Donate
  • Contact Us
  • Patient Care
    • PROSE Treatment
    • Find a PROSE Clinic
    • Conditions We Treat
    • Patient Stories
    • Patient Resources
    • Pediatrics
  • Technology
    • Our Products
    • Software Platforms
    • Manufacturing
  • Education
    • Visiting Clinicians
    • FitAcademy International
    • FitAcademy for Residents
    • FitAcademy Immersive
    • Ophthalmology Resident Lectures
  • Research
    • Clinical Trials and R&D Services
    • Research Studies
    • Publications
  • About
    • Our Approach
    • News
    • Our People
    • Our Partners
  • Needham PROSE Clinic
  • Find a PROSE Clinic
  • Donate
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

The Latest Research and Advances in Sjögren’s Treatment

June 16, 2025/0 Comments/in PROSE/by michele

*This article is a guideline only and not to be construed as medical advice. Always contact your eye care doctor with questions and for recommended treatment options. This article was updated on June 16, 2025 to reflect the change from Sjogren’s Syndrome to Sjogren’s disease.

Sjögren’s disease (or Sjögren’s Syndrome), a chronic autoimmune disorder affecting millions worldwide, primarily targets the body’s moisture-producing glands, leading to symptoms such as dry eyes and mouth. In recent years, groundbreaking research and significant strides have been made in treating Sjögren’s, offering hope to those living with this challenging condition. Here, we outline some of the latest research and advances in Sjögren’s disease treatment, shedding light on promising developments that could revolutionize patient care.

Biological Therapies: Unveiling Precision Medicine 

Cutting-edge research in Sjögren’s disease treatment has paved the way for personalized approaches, specifically targeting the underlying immune system dysfunction. Biological therapies, also known as biologics, are designed to modify the immune response at a molecular level. These therapies aim to address the root cause of Sjögren’s disease, providing a more targeted and efficient treatment option.

B-cell Targeted Therapies: Navigating the Immune System 

Recent studies have focused on the role of B-cells in Sjögren’s disease, leading to the development of B-cell targeted therapies. Medications such as rituximab, which depletes B-cells, have shown promise in reducing symptoms and improving overall quality of life for patients. This breakthrough offers a new avenue for treatment, especially for those who have not responded well to traditional approaches.

Neurostimulation: Pioneering Innovative Solutions 

Researchers are exploring neurostimulation as a potential treatment for Sjögren’s disease symptoms in a groundbreaking approach. By targeting the nerves that control tear and saliva production, neurostimulation aims to alleviate dry eyes and mouth. Early studies suggest that this innovative technique may provide relief for patients with persistent symptoms.

Cytokine Inhibitors: Balancing the Immune Response 

Cytokines, signaling proteins involved in the immune system response, play a crucial role in Sjögren’s disease. Recent advancements include the development of cytokine inhibitors, which aim to regulate the immune response and reduce inflammation. Clinical trials are underway to assess the efficacy and safety of these inhibitors, offering hope for improved symptom management.

Salivary Gland Gene Therapy: Targeting the Source

Gene therapy is emerging as a potential game-changer in Sjögren’s disease treatment. Researchers are investigating ways to deliver therapeutic genes directly to the salivary glands, promoting moisture production and mitigating symptoms. While still in the early stages of development, this approach holds promise for a more targeted and sustainable treatment option. This study explains more.

The landscape of Sjögren’s disease treatment is rapidly evolving, thanks to ongoing research and groundbreaking discoveries. From precision medicine with biological therapies to innovative approaches like neurostimulation and gene therapy, the latest advancements offer renewed hope for individuals living with this challenging autoimmune disorder. As research progresses, these developments not only enhance symptom management but pave the way for a brighter future for those affected by Sjögren’s.

Treatment for Eyes Affected by Sjögrens Syndrome

If you are experiencing eye pain and vision loss from the effects of Sjögren’s disease, you do not need to suffer. PROSE devices and scleral lenses are used to help individuals with severe and moderate dry eye and diseased and damaged corneas caused by Sjögren’s disease. While scleral lenses can help many people, PROSE treatment addresses the underlying eye condition and uses fully custom scleral lens devices that vault over the corneal surface, creating a reservoir between the cornea and the lens. The reservoir is filled with preservative-free saline to bathe and hydrate the eye all day, providing immediate relief and comfort, and promoting healing. PROSE also provides greatly improved vision. Think of the lens as a “new” cornea, which creates the shape of a typical, healthy cornea. This allows light to enter the eye at the correct angle for excellent vision and reduced light sensitivity. Learn more about PROSE.

/wp-content/uploads/2026/05/bostonsight-logo.svg 0 0 michele /wp-content/uploads/2026/05/bostonsight-logo.svg michele2025-06-16 16:33:332025-06-16 16:33:33The Latest Research and Advances in Sjögren’s Treatment

Scleral Lens Makeup Compatibility List Updated for June 2025

June 2, 2025/0 Comments/in Blog Posts, PROSE/by michele

We have recently posted the most recent scleral lens makeup compatible list here.

Patients can find this list under Patient Resources at any time, along with Recommended Solutions, PROSE Device Use and Care Guide, and Application and Removal Instructions.

/wp-content/uploads/2026/05/bostonsight-logo.svg 0 0 michele /wp-content/uploads/2026/05/bostonsight-logo.svg michele2025-06-02 18:13:162025-06-02 18:13:16Scleral Lens Makeup Compatibility List Updated for June 2025

Pages

  • About
  • Clinical Trials and R&D Services
  • Conditions We Treat
  • Contact Us
  • Dry Eye
  • Education
  • Find a PROSE Clinic
  • FitAcademy
  • FitAcademy for Residents
  • FitAcademy Immersive
  • FitAcademy International
  • GVHD
  • Home
  • Keratoconus
  • Manufacturing
  • Needham PROSE Clinic
  • News
  • Notice of Privacy Practices for Patients
  • Ophthalmology Resident Lectures
  • Our Approach
  • Our Partners
  • Our People
  • Our Products
  • Patient Care
  • Patient Information Booklet
  • Patient Resources
  • Patient Stories
  • Pediatrics
  • Post-Corneal Transplant
  • Post-LASIK
  • Practitioner IFU
  • Privacy Policy
  • PROSE Provider Payment Form
  • PROSE Treatment
  • Publications
  • Research
  • Research Studies
  • Sjögren’s Disease
  • Software Platforms
  • Stevens-Johnson Syndrome
  • Technology
  • Terms of Use
  • Visiting Clinicians
  • Ways to Support Us

Categories

  • Blog Posts
  • Clinic Updates
  • In the Media
  • Patient Stories
  • Press Release
  • PROSE
  • SCLERAL

Archive

  • May 2026
  • April 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • July 2025
  • June 2025
  • May 2025
  • January 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • July 2023
  • May 2023
  • March 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • March 2020
  • Patient Care
    • PROSE Treatment
    • Find a PROSE Clinic
    • Conditions We Treat
    • Patient Stories
    • Patient Resources
    • Pediatrics
  • Technology
    • Our Products
    • Software Platforms
    • Manufacturing Lab
  • Education
    • Visiting Clinicians
    • FitAcademy International
    • FitAcademy for Residents
    • FitAcademy Immersive
    • Ophthalmology Resident Lectures
  • Research
    • Clinical Trials and R&D Services
    • Research Studies
    • Publications
  • About
    • Our Approach
    • News
    • Our People
    • Partners
  • Needham PROSE Clinic
  • Donate
  • Contact Us

© 2026 BostonSight. All rights reserved.

Privacy PolicyTerms of Use

Scroll to top Scroll to top Scroll to top
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Save & Accept